Home / News / Supply of epilepsy drug disrupted until May

Supply of epilepsy drug disrupted until May


Facebook
Twitter
LinkedIn

By Beth Kennedy
Editor-in-chief

10 Jan 2020

The manufacturer Accord will be out of stock of the anti-epileptic drug Phenytoin Sodium NRIM 100mg capsules until ‘early May’.

The Department of Health and Social Care issued a supply disruption alert today (10 January), which contains advice on how to manage patients affected by the shortage.

The Pharmaceutical Services Negotiating Committee noted that as phenytoin is a category 1 anti-epileptic drug, it is recommended that patients are kept of a specific manufacturer’s product.

The negotiator noted that an alternative phenytoin sodium 100mg capsules manufactured by Flynn Pharma is available but warned that ‘switching to an alternative formulation requires monitoring and may also require specialist support, advice or referral’.


Want news like this straight to your inbox?


Latest News

India lifts ban on export of paracetamol
The central Indian government has lifted its three-month ban on exports of active pharmaceutical ingredients...
Test and trace: Pharmacy team members ‘wearing correct PPE’ will not have to self-isolate
Pharmacy team members in England who wear the correct personal protective equipment (PPE) will not...
Community pharmacy denied access to government’s new PPE supply
Community pharmacy will miss out on the government's latest personal protective equipment (PPE) supply arrangement...